News
The MACC has announced that personnel with a body mass index (BMI) exceeding 27 will be ineligible for promotion, beginning ...
The global prevalence of OA attributed to high BMI has steadily increased over the past 3 decades, particularly among women and in high-SDI regions.
Type 2 diabetes remission and weight loss rates are significantly higher among adults who replace diet beverages with water.
Breast cancer patients may have inferior recurrence-free survival after neoadjuvant chemotherapy if they are overweight or obese at diagnosis.
2h
HealthDay on MSNWeight Loss Continues Five Years After Tummy TucksPatients undergoing abdominoplasty experience continued weight loss up to five years postoperatively, according to a study ...
11h
Free Malaysia Today on MSNNo promotions for MACC officers with BMI above 27 from next yearChief commissioner Azam Baki says they have six months to meet the requirement or risk missing out on career progression.
Concerns over new age weight loss, diabetes drugs ...
A NEW Phase 3 trial has shown that a combination therapy of cagrilintide and semaglutide (CagriSema) can lead to substantial ...
5h
inews.co.uk on MSNFree weight-loss jabs to be available at shopping centres to scale up rolloutThe NHS rollout of Wegovy and Mounjaro will be scaled up, the Government has promised – without setting a date for when it ...
22h
News-Medical.Net on MSNMediterranean diet wins on weight but misses on memory in diverse aging populationA 14-month randomized trial in older African American adults with obesity found that adopting a Mediterranean diet, with or ...
Mr Streeting told LBC radio: “Weight-loss jabs are the talk of the House of Commons, half my colleagues are on them and are ...
11h
GlobalData on MSNAscletis begins dosing in Phase IIa trial of ASC30 for obesity treatmentAscletis Pharma has dosed the first obese or overweight subjects in the 13-week, multi-centre US Phase IIa trial of ASC30.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results